University of Texas, U.S.
Research from University of Texas, U.S., provides new insights into human health
Published in Physician Law Weekly, November 29th, 2006
This trend article about University of Texas, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A new study, "Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer," is now available. According to a study from the United States, "Neoadjuvant chemotherapy (NACT) increases the likelihood that breast conservation therapy for breast cancer patients will be successful. There is no available nomogram to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2006-11-29)
More Articles from Physician Law Weekly
- Allergy & Immunology
Medical-food products line developed for the dietary management of allergies - Avian Influenza
Control measures fail to stop spread of new H5N1 virus - Awards
ACP's electronic medical resource is ranked as a top evidence-based tool - Awards
Cardinal Health recognizes outstanding suppliers - Business & Finance
Amerigroup earns $24,604,000 net income or $0.46 per diluted share - Business & Finance
Cardiac Science reports revenue of $38.1 million in third quarter, up 39% over Q3 2005 - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
